How much dividend does Regenxbio pay?
Over the past 12 months, Regenxbio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Regenxbio is expected to pay a dividend of 0 USD.
Regenxbio Dividend 2024
Regenxbio Dividend
0 USD
Regenxbio Dividend yield
Ticker
RGNX
ISIN
US75901B1070
WKN
A140E0
How much dividend does Regenxbio 2024 pay?
According to the latest status from November 2024, Regenxbio paid a total of 0 USD per share in dividends within the last 12 months. With the current Regenxbio price of 11.16 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Regenxbio Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the Regenxbio Dividend Safe?
Regenxbio has been increasing the dividend for 0 years.
Over the past 10 years, Regenxbio has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Regenxbio's Dividend Distributions
Regenxbio’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Regenxbio's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Regenxbio's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Regenxbio’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Regenxbio Aktienanalyse
What does Regenxbio do?
Regenxbio Inc is a biopharmaceutical company that specializes in the development of AAV-based gene therapies for rare genetic diseases. The company was founded in 2009 in Maryland, USA and has since developed an impressive portfolio of therapy options. The history of Regenxbio Inc begins with the realization that gene therapies offer a promising way to treat rare genetic diseases for which there are currently no cures. However, at that time, there were still many technical and regulatory hurdles to overcome. Regenxbio took on these challenges and specialized in the development of adeno-associated viruses (AAV) as vectors for the transfer of therapeutic genes, as these viruses are ideally suited for this purpose. The business model of Regenxbio Inc is based on licensing its technology platform to other companies, which can then develop their own gene therapies. The company has already formed partnerships with major pharmaceutical companies such as AstraZeneca and Novartis, who utilize Regenxbio's technology platform to develop new therapy options for rare diseases. A significant aspect of Regenxbio Inc is the discovery and development of gene therapies for rare diseases. These include diseases such as choroideremia syndrome and mucopolysaccharidosis type I, among others. The company has already conducted clinical trials that have shown promising results and has received approval in the EU. Regenxbio aims to replace invasive and complicated treatments with gene therapy options. Additionally, Regenxbio Inc also offers services in the manufacturing of AAV-based gene therapies. The company supports other firms in the production and quality control of AAV vectors required for the manufacturing of gene therapies. This business sector plays a crucial role in the distribution of therapies to the market. The ultimate goal of Regenxbio Inc is to improve the quality of life for individuals suffering from rare genetic diseases through the development and commercialization of gene therapies. With innovative technologies and partnerships with other pharmaceutical companies, the company has already established an important role in the field of gene therapy development. Overall, the company has a very positive future outlook and will remain under observation in the healthcare industry. Regenxbio is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Regenxbio stock
What is the dividend yield of Regenxbio?
The current dividend yield of Regenxbio is .
When does Regenxbio pay dividends?
Regenxbio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Regenxbio?
Regenxbio paid dividends every year for the past 0 years.
What is the dividend of Regenxbio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Regenxbio located?
Regenxbio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Regenxbio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Regenxbio from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Regenxbio pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Regenxbio in the year 2023?
In the year 2023, Regenxbio distributed 0 USD as dividends.
In which currency does Regenxbio pay out the dividend?
The dividends of Regenxbio are distributed in USD.
Andere Kennzahlen von Regenxbio
Our stock analysis for Regenxbio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Regenxbio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
